SCHEMBL14097703

SCHEMBL14097703

CC(C)NC(=O)Nc1nc2cc(-c3cccnc3)cc(C#N)c2o1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LRRK2 Q5S007 1/20 0.40
▸ PTGS2 P35354 2/20 0.39
▸ DYRK1A Q13627 1/20 0.39
▸ EGFR P00533 1/20 0.38
▸ XDH P47989 1/20 0.38
▸ KDM4E B2RXH2 4/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ MAPT P10636 1/20 0.37
▸ PKM P14618 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ TP53 P04637 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ ABL1 P00519 1/20 0.37
▸ AR P10275 1/20 0.36
▸ CTSL P07711 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14097694 0.86 ABL1 (0.52) ABL1
SCHEMBL14097683 0.71 ABL1 (0.52) ABL1
SCHEMBL14097705 0.70 ABL1 (0.48) ABL1
SCHEMBL14097550 0.69 ABL1 (0.62) DYRK1AALDH1A1HPGDHSD17B10ABL1
SCHEMBL14097685 0.69 POLB (0.48) DYRK1AKDM4EALDH1A1TP53RAB9A
SCHEMBL14097708 0.68 ABL1 (0.48) NPC1RAB9ASMN1; SMN2ABL1AR
SCHEMBL14395666 0.67 CTSL (0.36) DYRK1AXDHKDM4EALDH1A1MAPT
SCHEMBL14097710 0.66 ABL1 (0.46) KDM4EALDH1A1SMN1; SMN2ABL1
SCHEMBL14097682 0.65 ABL1 (0.60) KDM4EALDH1A1NPC1TP53HPGD
SCHEMBL14097515 0.65 ABL1 (0.67) ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7414046-B2 Gyrase inhibitors and uses thereof VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-08-19 — — US disclosed
US-7414046-B2 Gyrase inhibitors and uses thereof VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-08-19 — — US disclosed
US-RE40245-E1 Gyrase inhibitors and uses thereof VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-04-15 — — US disclosed
US-RE40245-E1 Gyrase inhibitors and uses thereof VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-04-15 — — US disclosed
EP-1341769-B1 BACTERIAL GYRASE INHIBITORS AND USES THEREOF VERTEX PHARMA (US) 2007-10-17 — — EP disclosed
Send feedback